ORCID as entered in ROS

Select Publications
2010, 'Perceptions of the impact of health-care services provided to palliative care clients and their carers', International Journal of Palliative Nursing, 16, pp. 274 - 284
,2009, 'Changes in general nurses' knowledge of alcohol and substance use and misuse after education', Perspectives in Psychiatric Care, 45, pp. 128 - 139, http://dx.doi.org/10.1111/j.1744-6163.2009.00213.x
,2009, 'The meta-analysis graph: Clearing the haze', Clinical Nurse Specialist, 23, pp. 57 - 60, http://dx.doi.org/10.1097/NUR.0b013e31819971fd
,2009, 'Does implementation of clinical practice guidelines change nurses' screening for alcohol and other substance use?', Contemporary Nurse, 33, pp. 13 - 19, http://dx.doi.org/10.5172/conu.33.1.13
,2008, 'Administration of medications by enrolled nurses: Perceptions of metropolitan and non-metropolitan registered nurses and nursing unit managers', Contemporary Nurse, 27, pp. 237 - 245, http://dx.doi.org/10.5172/conu.2008.27.2.237
,2007, 'Drink a little; take a few drugs: Do nurses have knowledge to identify and manage in-patients at risk of drugs and alcohol?', Drug and Alcohol Review, 26, pp. 545 - 552, http://dx.doi.org/10.1080/09595230701499167
,2024, 'Does use of smoking cessation pharmacotherapies during pregnancy increase the risk of congenital malformations in infants: Findings from a multi-national study', Edinburgh, Scotland, United Kingdom, presented at Society for Research on Nicotine and Tobacco Annual Meeting, Edinburgh, Scotland, United Kingdom, 20 March 2024 - 23 March 2024
,2023, 'Prevalence of smoking cessation pharmacotherapy use during pregnancy: a multi-national population-based study', Sydney, presented at Centre of Research Excellence in Medicines Intelligence Symposium 2023, Sydney, 02 November 2023 - 03 November 2023
,2023, 'The risk of congenital malformations in infants exposed in the first trimester to smoking cessation pharmacotherapies: A multi-national cohort study', Sydney, presented at Centre of Research Excellence in Medicines Intelligence Symposium 2023, Sydney, 02 November 2023 - 03 November 2023
,2023, 'Utilisation of smoking cessation pharmacotherapies during pregnancy: a multi-national population-based study', in DRUG AND ALCOHOL REVIEW, WILEY, Adelaide, South Australia, pp. S155 - S156, presented at APSAD Australasian Professional Society on Alcohol and other Drugs 2023, Adelaide, South Australia, 27 October 2023 - 30 October 2023
,2023, 'The safety of quit smoking medications during pregnancy: the risk of congenital malformations in infants', UNSW Sydney, presented at National Drug and Alcohol Research Centre Symposium 2023, UNSW Sydney, 26 October 2023
,2023, 'First trimester exposure to smoking cessation pharmacotherapies and the risk of major congenital malformations: A multi-national cohort study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Halifax, Nova Scotia, Canada, pp. 539 - 539, presented at 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Halifax, Nova Scotia, Canada, 23 August 2023
,2022, 'Utilisation of elective spinal procedures in NSW (Preliminary findings)', Sydney, presented at Australia & New Zealand Musculoskeletal Clinical Trials Network Scientific Meeting 2022, Sydney, 18 April 2022 - 19 April 2022
,2021, 'THE COMPARATIVE CARDIOVASCULAR SAFETY OF SMOKING CESSATION PHARMACOTHERAPIES', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S78 - S79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Nursing digital leadership through advanced analytics of electronic nursing admission forms', Sydney, presented at Australian College of Nursing National Nursing Forum, Sydney, 26 October 2021
,2020, 'Rates of elective spinal procedures in NSW by public – private – workers compensation schemes', Sydney, presented at Australian and New Zealand Low Back Pain Research Network, Sydney, 17 September 2020
,2019, 'Trajectories of antipsychotic use before and during pregnancy and related maternal and birth characteristics', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, pp. 216 - 216, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864
,2019, 'Risk of Major Cardiovascular Events Associated with Varenicline and Nicotine Replacement Therapy: An Australian Population-Based Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785600033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Safety of renin-angiotensin system blockers in early pregnancy', Sydney, presented at 54th Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Sydney, 08 September 2018
,2018, 'Varenicline is more effective than nicotine replacement therapy during pregnancy: Findings from the smoking mums (maternal use of medications and safety) study', Prague, Czech Republic, presented at The 34th International Society for Pharmacoepidemiology Annual Conference, Prague, Czech Republic, 22 August 2018 - 26 August 2018
,2018, 'First trimester exposure to varenicline was not associated with increased risk of major birth defects: Findings from the smoking MUMS (Maternal Use of Medications and Safety) study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 352 - 352, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893803093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Healthcare providers' concerns regarding smoking cessation pharmacotherapies in pregnancy: calls to a teratology information service', in TOBACCO INDUCED DISEASES, EUROPEAN PUBLISHING, pp. 322 - 322, http://dx.doi.org/10.18332/tid/84029
,2017, 'Risk of adverse perinatal outcomes associated with early pregnancy use of renin-angiotensin system blockers for the management of chronic hypertension', Brisbane, presented at ISPE's 10th Asian Conference on Pharmacoepidemiology, Brisbane, 29 October 2017
,2017, 'Birth Outcomes Associated with the Use of Smoking Cessation Pharmacotherapies in Pregnancy: Findings from the Smoking MUMS (Maternal Use of Medications and Safety) Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 435 - 436, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437104300321&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Is the Use of Smoking Cessation Pharmacotherapies During Pregnancy Consistent with Clinical Guidelines? Findings from the Smoking MUMS (Maternal Use of Medications and Safety) Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 506 - 507, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437104300436&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Prevalence of renin-angiotensin system (RAS) blockers exposure during pregnancy and the clinical indications: A Population-Based Cohort Study in NSW (2005-2012).', Canberra, presented at Perinatal Society of Australia and New Zealand, Canberra, 02 May 2017
,2016, 'Algorithms for assessing person-based consistency among linked records for the investigation of maternal use of medications and safety', in International Journal for Population Data Science, Swansea University, Swansea, pp. 212, presented at International Population Data Linkage Network Conference, Swansea, 24 August 2016 - 26 August 2016, http://dx.doi.org/10.23889/ijpds.v1i1.212
,2015, 'Variation in the use of primary care services for diabetes management according to country of birth and geography among older Australians', Melbourne, Australia, presented at 9th Health Services and Policy Research Conference, Melbourne, Australia, 07 December 2015 - 09 December 2015
,2013, 'Enhancing ascertainment of smoking in pregnancy using linked population health data', Wellington, New Zealand, presented at The 8th Health Services and Policy Research Conference, Wellington, New Zealand, 02 December 2013 - 04 December 2013
,2012, 'Continuity of care for patients with diabetes in Australian general practice and its impact on health service use', National Convention Centre, Canberra, presented at 2012 Primary Health Care Research Conference - Inform, influence, implement: research improving policy & practice, National Convention Centre, Canberra, 18 July 2012 - 20 July 2012
,2011, 'Diabetes type 2 risk factors, management and health service use according to remoteness of residence', Adelaide, South Australia, Australia, presented at 7th Health Services and Policy Research Conference, Adelaide, South Australia, Australia, 05 December 2011 - 07 December 2011
,2011, 'The 45 and up study: Validating self reported Diabetes Mellitus Status', Thomas & Rachel Moore Education Centre, Liverpool Hospital, presented at Ingham Institute for Applied Medical Research 6th Annual Research & Teaching Showcase "Improving the health and wellbeing of the South West", Thomas & Rachel Moore Education Centre, Liverpool Hospital, 02 December 2011 - 02 December 2011
,'Emergency department attendance after telephone triage', in International journal of population data science
,'Refining an antidepressant-based indicator to improve the ascertainment of depression from Australian administrative data', in International journal of population data science
,2024, 'Retention in opioid agonist treatment following childbirth and associated factors', Wesley Conference Centre, Sydney NSW, presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024
,2024, 'Effectiveness of prescription smoking cessation pharmacotherapies during pregnancy: a multi-national study', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024
,2024, 'Retention in opioid agonist treatment following childbirth and associated factors', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=97s
,2024, 'Trends in the use of opioid agonist treatment for opioid dependence in pregnancy', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=1850s
,2024, 'Use of opioid agonist therapy in pregnancy: Timing of initiation and treatment retention', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=2664s
,2022, Health Care Homes trial final evaluation report, Volume 1: Summary report, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-summary-report.pdf
,2022, Health Care Homes trial final evaluation report, Volume 2: Main report, https://www.health.gov.au/resources/publications/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022
,2022, Health Care Homes trial final evaluation report, Volume 3: Methods and data supplement, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-methods-and-data-supplement.pdf
,2021, Health Care Homes PHN Benchmark Report: July 2020 - December 2020 (Round 5)
,2021, Health Care Homes Practice Benchmark Report: July 2020 - December 2020 (Round 5)
,2021, Evaluation of the Health Care Homes program - Interim evaluation report 2020 Volume 1: Summary report, https://www1.health.gov.au/internet/main/publishing.nsf/Content/Evaluation-of-the-Health-Care-Homes-Program
,2021, Evaluation of the Health Care Homes program – Interim evaluation report 2020, Volume 2: Main report
,2021, Evaluation of the Health Care Homes program – Interim evaluation report 2020, Volume 3: Evaluation progress
,2020, Health Care Homes PHN Benchmark Report: January 2020 - June 2020 (Round 4)
,2020, Health Care Homes Practice Benchmark Report: January 2020 - June 2020 (Round 4)
,2020, Evaluation of the Health Care Homes program - Interim evaluation report 2019, Volume 1: Summary report
,